The board of administrators of IDEX Biometrics ASA has resolved to situation 299,381,600 new shares at NOK 0.01 per share to workers, contractors and administrators within the IDEX group (“Personnel Placement”). The aim of the Personnel Placement is to incentivise the personnel within the implementation of the amended marketing strategy and commercialisation of the corporate’s merchandise.
The Personnel Placement is in accordance with the decision by the extraordinary basic assembly of IDEX Biometrics ASA held on 11 April 2025, the place the board was authorised to situation shares on phrases equal to the phrases within the debt conversion that was accepted on the similar assembly.
The shares are restricted for 18 months from the date of issuance and might not be bought or in any other case transferred in the course of the restriction interval. 1/3 of the shares are launched from the restriction after 6 months and one other 1/3 are launched after 12 months. Within the occasion a holder resigns or is terminated from employment or service, the corporate has the suitable to repurchase the holder’s restricted shares at sure phrases.
The Board has thought-about the difficulty to the Personnel in mild of the equal therapy obligations below the PLCA, the Norwegian Securities Buying and selling Act, the principles on equal therapy below Oslo Rule Ebook II for corporations listed on the Oslo Inventory Trade and the Oslo Inventory Trade’s Tips on the rule of equal therapy and deems that the proposed Personnel Placement is in compliance with these necessities. The Board holds the view that it will likely be within the frequent curiosity of the Firm and its shareholders to incentivize the Firm’s Personnel by issuance of the Provide Shares, each within the brief time period and in the long run. The variety of Provide Shares represents roughly 6,7 % of the entire variety of excellent shares within the Firm, and the dilutive impact for the Firm’s shareholders is restricted. The subscription value for the Provide Shares, which was introduced to the EGM because the supposed situation value, is NOK 0.01, and the subscription value, earlier than bearing in mind the lock up, consequently represents a 78 % low cost to the closing value of the Firm’s shares on Oslo Børs on 13 June 2025. Taking into consideration the lock up interval and the volatility of the shares, the low cost will differ from no low cost in any respect to approx. 25 %. Whereas the low cost may be deemed important, the Firm is of the view that the variety of Provide Shares issued, the truth that the issuance is made to the Personnel solely, the EGM has particularly accepted the framework for this fairness situation, the Provide Shares shall be topic to gross sales restrictions by means of a reverse vesting schedule with buying and selling and switch restrictions over 18 months, together with with an choice for the Firm to repurchase the Provide Shares upon termination or resignation previous to the top of the 18-month interval, collectively make sure that the Firm is in compliance with its equal therapy obligations.
Following registration of the share capital enhance, the corporate’s share capital shall be NOK 47,310,125.99, divided into 4,731,012,599 shares every with a nominal worth of NOK 0.01.
Contact particular person
Kristian Flaten, CFO, Tel.: +47 950 92322
E-mail: ir@idexbiometrics.com
About IDEX Biometrics
IDEX Biometrics ASA (IDEX) is a world expertise chief in fingerprint biometrics, providing authentication options throughout funds, entry management, and digital id. Our options deliver comfort, safety, peace of thoughts and seamless consumer experiences to the world. Constructed on patented and proprietary sensor applied sciences, built-in circuit designs, and software program, our biometric options goal card-based functions for funds and digital authentication. As an industry-enabler we associate with main card producers and expertise corporations to deliver our options to market.
For extra info, go to http://www.idexbiometrics.com
About this discover
This discover was issued by Erling Svela, VP of finance, on 10 June 2025 at 23:50 CET on behalf of IDEX Biometrics ASA. The shall be disclosed in accordance with part 5-8 of the Norwegian Securities Buying and selling Act (STA) and revealed in accordance with part 5-12 of the STA.
